The medical cannula market is estimated to reach USD 229.5 million in 2024. It is estimated that revenue will increase at a CAGR of 6.9% between 2024 and 2034. The market is anticipated to reach USD 447.0 million by 2034.
Medical Cannula are thin tubes inserted into the body cavity for delivery of medication, nutritional fluids and oxygen. There are various types of medical cannula product available in the market such as guedel, yankauer, berman, frazier, spackmann, barron, novak, poole, robertazzi, bellucci, brackman, karman, others.
These cannulas are used in hospital settings for patient towards performing various procedures which includes drawing of blood, drug administration, administration of IV fluids and nutrition supplements. Many medical cannulas are often used in nasal cavity towards delivery of supplement oxygen for patient with chronic respiratory disorders.
Medical cannulas also holds extensive usage in administration of anesthetic gases in various critical procedures. These medical cannulas are available in multiple size and in different material depending the intended use.
Medical Cannula Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 215.5 million |
| Estimated Size, 2024 | USD 229.5 million |
| Projected Size, 2034 | USD 447.0 million |
| Value-based CAGR (2024 to 2034) | 6.9% |
With rising prevalence of chronic disease which involve frequent hospitalization, medical cannulas play a pivotal role in delivery of medications & IV fluids in an emergency or in-patient settings. For example, according to Centers for Disease Control and Prevention data there are approximately 38.4 million people suffering from diabetes in the USA, for which continuous insulin is delivered through cannulas.
As per the WHO, cardiovascular conditions accounts for 13.2 million deaths annually around the world. This requires cannulas during emergencies and surgeries for accessing the medication in time. Similarly, patients with COPD and cancer require additional oxygen and chemotherapy medication administration via specialized cannulas, thus increasing the demand further.
Another key factor that has greatly influenced the cannula market is the shift towards minimal invasive surgery (MIS). These techniques have less trauma and shorter recovery periods, hence the requirement for cannulas designed specifically for these operations increases correspondingly. Sophisticated cannula designs that can achieve precise navigation through complex anatomy are finding great demand from healthcare providers that are embracing MIS.
Furthermore, growing acceptance of cosmetic procedures expands the market. A surge in minimally invasive aesthetic treatments involving liposuction and dermal fillers, which involve administering active ingredients through cannulas, boosts demand for medical cannula.
Regulatory hurdles, risks of nerve injury during insertion, and high costs associated with advanced cannulas are some of the market restrain that hampers the growth. The medical cannula market is expected to have huge growth on account of evolving healthcare needs and technological advancements.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The below table presents the expected CAGR for the global medical cannula market over several semi-annual periods spanning from 2024 to 2034. In the first half (H1) of the decade from 2024 to 2034, the business is predicted to surge at a CAGR of 8.2%, followed by a slightly lower growth rate of 7.8% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 8.2% (2023 to 2033) |
| H2 | 7.8% (2023 to 2033) |
| H1 | 6.9% (2024 to 2034) |
| H2 | 6.7% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to decrease slightly to 6.9% in the first half and remain relatively moderate at 6.7% in the second half. In the first half (H1) the market witnessed a decrease of 100 BPS while in the second half (H2), the market witnessed a decrease of 90 BPS.
Increased Prevalence of Chronic Diseases Driving demand for Medical Cannula Market
As per AHA Hospital Statistics, total number of admission across all 6,129 hospitals in United States is 34,011,386 in 2023, out of which 80-90% of the in-patient require IV administration during the length of stay. Cannulas play a crucial role in delivering medications for the same. As per WHO data cardiovascular diseases accounts for 13.2 million deaths annually across the globe. Cannulas are crucial in managing these conditions they enable quick access for medication delivery during emergencies or surgeries.
As per CDC data COPD affects approximately 16 million Americans, and often those patients require supplemental oxygen via nasal cannulas, especially during exacerbation of their disease. In the realm of oncology, it is estimated by the American Cancer Society that in the year 2023 alone, over 1.9 million new cancer diagnoses will be made in the USA, many requiring the administration of chemotherapy through IV cannulas for precise dosing and rapid delivery.
Besides, about 37 million adults in the USA have CKD, and most of them require dialysis treatment, which involves the use of special cannulas to access blood. Lastly, asthma affects approximately 27 million Americans and, depending on the case, will require different treatments that could involve cannulas for delivering medication during acute attacks.
All these chronic diseases together indicate that cannulas play a vital role in effective treatment and recovery, which ultimately improves outcomes. The increase in prevalence of these chronic diseases acts as a significant driver of the medical cannula market.
Growing Adoption of Minimal Invasive Surgery Has Increase the Demand for Specialized Medical Cannula
There is a greater inclination towards Minimally Invasive Surgery (MIS) techniques because of the numerous advantages it offers. MIS led to less trauma, shorter recovery times, and minimal scarring. This shift in surgical practice has created an increased demand for cannulas specially designed to assist these procedures.
As healthcare providers increasingly adopt MIS, more sophisticated cannula designs are necessary to navigate this complex anatomy. Cannulas associated with MIS are often small and even flexible, permitting surgeons to execute complex manipulations with smaller incisions.
By reducing the surgical site, many patients experience an enhanced outcome: shorter hospital stays and consequently lower healthcare costs. That makes MIS increasingly appealing to patients and healthcare systems alike.
Technological advancements in the manufacturing of cannulas also support this growth. Biocompatible materials, along with other safety features, are being introduced to make the working of cannulas employed in MIS more functional and safe. Overall, the increasing trend of minimally invasive techniques is majorly affecting the outlook of the medical cannula market, thereby increasing the demand for innovative solutions to meet these emerging surgical practices.
Increasing Number Cosmetic Procedures Performed Offers an Opportunity for Market Growth
People's desire to look good and regain a youthful appearance has resulted in a boom in the cosmetic surgery market. According to the procedural statistic data release by American Society of Plastic Surgeons in 2023 there were 347,782 liposuction procedure performed in United States.
Minimally invasive procedures, such as liposuction and dermal fillers are gaining popularity due to their efficacy and lessened recovery times. Most of these procedures use cannulas for administration, thus increasing demand for these devices. Non-invasive treatments are also in high demand since patients are more inclined toward options that involve minimum discomfort and downtime, hence increasing the demand in the cannula market.
Besides, technological advances in the cosmetic industry have increased safety and efficiency. Social media promotes the standards of beauty, and this influences people to undergo aesthetic procedures, thus increasing the number of procedures carried out.
Hence, the wide acceptance of cosmetic procedures within society, advanced technologies, and the concentration on appearance are all factors that work together to drive the demand for cannulas within aesthetic medicine. This trend will continue as more individuals seek cosmetic enhancements that fit with today's beauty ideals.
Regulatory Challenge and Complication associated with the Medical Cannula Hinder the Market Growth for the same
Regulatory bodies, such as the FDA have stringent requirements for safety and effectiveness that may increase the time a new product needs to gain approval. This uncertainty may further discourage innovation and delay the introduction of advanced cannula technologies into the market.
Also, nerve injury with cannula use may occur. Complications during the time of insertion can also make health care professionals reluctant to use certain types of cannulas, which would dampen the overall demand. Additionally, a shortage in skilled healthcare professionals who are properly trained in performing the best cannulation techniques serves as a barrier to effective usage, resulting in more complications and negative patient outcomes.
Further, high costs of advanced cannulas also restrain market growth, particularly in regions with low healthcare budgets. Many healthcare facilities may opt for lower-cost alternatives, thereby limiting the adoption of innovative products. Besides, intense competition and market saturation are major factors. The presence of numerous players leads to price wars, decreasing profit margins, and acting as a barrier to investing in new product development.
These restraining factors together create a challenging environment for the medical cannula market, which requires strategic responses from manufacturers and healthcare providers to effectively overcome these challenges. Regulatory uncertainties, training programs, and cost management will be the key areas that need to be addressed for the growth of this sector.
Principal Consultant
The medical cannula industry recorded a CAGR of 4.3% between 2019 and 2023. According to the industry, medical cannula generated USD 215.5 million in 2023, up from USD 174.8 million in 2019.
The medical cannula market was characterized by a focus on traditional surgical procedures, with cannulas mainly employed in an inpatient setting. Demand had been high, depending on increasing number of surgeries and requirements for effective modes of drug delivery. Volumes of surgeries took a temporary hit as the COVID-19 pandemic set in. The postponing of elective procedures translated to a negative impact on cannula usage for the period.
The market is recovering from the pandemic impact due to a high volume of minimally invasive surgeries. Minimally invasive surgeries offers several advantage over traditional surgery practice. This advantages has led to growing adoption of the Minimal invasive procedures.
There is also an increase in diabetes and cardiovascular diseases that require frequent medical procedures with the use of cannulas. The market is also influenced by technology, as innovations like safety-engineered cannulas and smart devices make the treatment much safer.
The market is expected to continue evolving, at a CAGR of 6.9% from 2024 to 2034. Key trends include the growing demand for home healthcare solutions and outpatient procedures that extend cannula applications beyond their traditional use. The increasing focus on sustainability encourages manufacturers to develop eco-friendly cannulas. Cosmetic surgery will also see significant growth as people are becoming more concern about their appearance.
Companies in the Tier 1 sector account for 45.5% of the global market, ranking them as the dominant players in the industry. Tier 1 players’ offer a wide range of product and have established industry presence.
Having financial resources enables them to enhance their research and development efforts and expand into new markets. Strong brand recognition and a loyal customer base provide them with a competitive edge. Prominent companies within Tier 1 include AdvaCare Pharma, Braun SE, Teleflex Incorporated and ResMed Inc
Tier 2 players dominate the industry with a 32.5% market share. Tier 2 firms have a strong focus on a specific Product Type and a substantial presence in the industry, but they have less influence than Tier 1 firms. The players are more competitive when it comes to pricing and target niche markets.
New Product Type and services will also be introduced into the industry by Tier 2 companies. Tier 2 companies include Fisher & Paykel Healthcare Limited, Polymedicure, B. Braun SE, Salter Labs, ICU Medical, Inc., and others.
Compared to Tiers 1 and 2, Tier 3 companies have smaller revenue spouts and less influence. Those in Tier 3 have smaller work force and limited presence across the globe.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the industry analysis for the medical cannula market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, and Middle East and Africa (MEA), is provided. The United States is anticipated to remain at the forefront in North America through 2034. India is projected to witness a CAGR of 8.2% from 2024 to 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| USA | 6.3% |
| Canada | 7.4% |
| Germany | 5.1% |
| France | 7.5% |
| Italy | 7.7% |
| UK | 7.3% |
| Spain | 8.1% |
| China | 6.7% |
The United States is marked by the growing burden of chronic illnesses such as diabetes and cardiovascular disorders, which demand frequent medical procedures needing vascular access. About 80% of elderly persons have at least one chronic condition, and many are hospitalized leading to the rising demand for cannula required in surgical and non-surgical procedures.
The USA healthcare system is making large investments in advanced medical technologies, thus enabling hospitals to adopt innovative cannula designs that improve patient outcomes. Government initiatives put more emphasis on easy accessibility and affordability of healthcare, thereby acting as a catalyst for market growth.
The high level of healthcare spending in the USA supports ongoing research and development. This support emergence of new product approvals and market entries by leading companies. The COVID-19 pandemic has also emphasized the use of cannulas for respiratory support. Collectively the above factors position the USA as a leader in the medical cannula market, with projections indicating significant growth in the coming years.
By 2050, the population aged 65-plus in Germany is likely to reach nearly one-third of all citizens, increasing by 41% to 24 million in 2050. This trend also has a consequence of an increasing incidence of age-related disease conditions such as cardiovascular conditions and diabetes, which involve recurring medical interventions requiring cannula in their treatment.
Germany has a very strong welfare system, with a compulsory insurance for long-term care. This ensures that elderly patients are covered in the services they need and require the use of cannulas in treatment. This demand is further supported by government efforts towards improving home-based care solutions, as many elderly prefer staying at home instead of institutionalized care.
Besides, the integration of e-health technologies into the healthcare framework enables better management of chronic conditions and improves patient outcomes, thus driving the need for advanced vascular access devices like cannulas. All these factors create a favorable atmosphere in which the medical cannula market can grow in the German economy.
The large population of 28% living above 65 years increases the demand for healthcare services, especially for chronic ailments that require vascular access and, therefore, the use of medical cannulas.
These needs have been preemptively addressed by the Japanese government through various healthcare reforms and policies towards better access to advanced medical technologies. For example, Health Care 2035 focuses on establishing a value-oriented, integrated healthcare system in which quality supersedes quantity in care provided to all citizens, irrespective of age or socioeconomic background. Such a commitment to universal health coverage provides fertile ground for innovative medical devices such as cannulas to thrive.
Furthermore, Japan is the innovator in healthcare technologies and invests hugely in robotics and telemedicine. The integration of such technologies enhances surgical capabilities and patient monitoring, thus giving rise to the demand for specialized cannulas. Therefore, Japan continues to put emphasis on health technology and elder care solutions, and the medical cannula market is set to see continued growth.
A description of the leading segments in the industry is provided in this section. The vascular access segment held 68.9% of the value share in 2024. Based on the end user, hospitals held 52.9% of the market in 2024.
| Medical Procedure | Vascular Access |
|---|---|
| Value Share (2024) | 68.9% |
Increasing incidence of diabetes, cardiovascular diseases, and cancers creates a need for vascular access. Most of these conditions are for long-term, hence the demand for vascular access devices is increased significantly. The global increase in the elderly population, who are more susceptible to chronic diseases requiring vascular access, is another significant factor driving market growth.
There is an increasing trend of preference for minimally invasive surgical procedures that often depend on vascular access to provide fluid management and medication. Improving designs and materials for the catheter increase comfort and limit complications, thus making the procedure much easier for both the patients and professional caregivers.
The rise in home health services is also boosting demands for user-friendly vascular access systems that can be well managed outside the conventional environment of a clinical setting. This trend reflects a wider trend toward patient-centered care and convenience. Hence owing to the combination of the aforementioned factor such the vascular access segment is domination the medical cannula market.
| End User | Hospitals |
|---|---|
| Value Share (2024) | 52.9% |
Hospitals are characterized by large number of patients visiting for various medical conditions. This led to huge demand for cannulas within various hospital department. According to the survey conducted by National Center for Health Statistics more 139.8 million visit emergency department annually.
The increase in minimally invasive surgeries (MIS) that require specialized medical cannula have led to a higher adoption of cannulas within hospital settings. These procedures often necessitate the use of specialized cannulas for effective patient management, further solidifying hospitals' role as primary consumers.
Additionally, government initiatives promoting healthcare access and funding for hospital infrastructure enhance the capacity and capability of hospitals to utilize advanced medical devices like cannulas. Hospitals benefit from a greater availability of resources, including skilled personnel and comprehensive facilities, enabling them to implement a wide range of medical procedures that require cannula use. This multifaceted support system positions hospitals at the forefront of the cannula market's growth trajectory.
Market player are adoption wide array of growth strategies to increase their market share. Companies are developing new innovative product with unique design, functionality etc. and getting patent over it. This move provide sufficient time for the inventor company to recover their research cost and gain lucrative profit for some time.
Another method to gain competitive edge which is mostly adopted by the established firm is to acquire small company with unique product portfolio. Later the established company owing to its economies of scale can scale the product at global level gain hefty revenue.
Recent Industry Developments in the Medical Cannula Market
In terms of product type, the industry is segmented into guedel, yankauer, berman, frazier, spackmann, barron, novak, poole, robertazzi, bellucci, brackman, karman, and others
In terms of medical procedure, the industry is bifurcated Vascular Access, Surgery, Intubation, Lipofilling, Suction, Irrigation, Biopsy, Insufflation, Hysterography, Insemination, and Cardioplegia.
In terms of size, the industry is segmented into 14G, 16G, 18G, 20G, 22G, 24G, and 26G
In terms of Material, the industry is bifurcated into Latex, Latex-Free, and Neoprene.
In terms of end user, the industry is segmented into Hospitals, Ambulatory Surgical Center, Clinics, and Other
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, the Middle East, and Africa have been covered in the report.
Medical Cannula industry is expected to increase at a CAGR of 6.9% between 2024 and 2034.
The vascular access segment is expected to occupy a 68.9% market share in 2024.
The market for medical cannula is expected to reach USD 447.0 million by 2034.
The United States is forecast to see a CAGR of 6.3% during the assessment period.
The key players in the medical cannula industry include AdvaCare Pharma®,Hindustan Syringes & Medical Devices Ltd, JCM MED, Teleflex Incorporated ResMed Inc., Fisher & Paykel Healthcare Limited, Polymedicure, B. Braun SE Salter Labs, ICU Medical, Inc. & others
Explore Healthcare Insights
View Reports
Medical Cannula Market
